Skip to main content

Mylan-Beclo Aqueous nasal spray

This product is manufactured by Mylan using the ingredient beclomethasone dipropionate.

This product is taken via nasal inhalation.

Why is it prescribed?

Beclomethasone is used to control the signs and symptoms of asthma that are responsive to orally inhaled corticosteroids. It is also used as a nasal spray to relieve stuffiness, sneezing, runny nose, and other symptoms associated with allergies where inflammation of the lining of the nose causes it to run. Beclomethasone nasal spray is also used to slow the rate of recurrence of nasal polyps after surgical removal.

Mylan-Beclo Aqueous nasal spray is intended for nasal inhalation only. Your doctor or pharmacist should have instructed you on the proper use and care of your Mylan-Beclo Aqueous nasal spray. The very first time the spray is used, prime (load) the pump as instructed until a fine spray appears. It is now ready for use.

To use the spray:

  • Clear the nasal passage by gently blowing your nose.
  • Tilt your head forward slightly, then insert the nozzle of the spray into one nostril and close the other nostril with your finger.
  • Press down on the nozzle once while breathing in through the nose and keeping your mouth closed.
  • Exhale through your mouth. If using 2 sprays per nostril, repeat this process.


It is not meant to give you instant relief of your nasal congestion but to correct the underlying problem responsible for your symptoms. Check with the doctor if you notice signs of infection in your nose, throat or sinus or if repeated unusual bleeding occurs.
Remember to gently shake the bottle before each use.
Your Mylan-Beclo Aqueous nasal spray should be stored at room temperature (15 to 30 degrees centigrade).


Alternatives

Other products that have the same ingredient as Mylan-Beclo Aqueous nasal spray are •Apo-Beclomethasone nasal spray •QVAR® MDI •

See other products used in the treatment of •allergic rhinitis •asthma •hay fever •perennial rhinitis •rhinitis •runny nose •seasonal rhinitis •sleep apnea •

The usual recommended dose of beclomethasone nasal spray for adults and children over 6 years of age is 2 sprays (100 mcg) into each nostril twice daily. The daily dosage should not exceed 12 sprays (600 mcg) for adults or 8 sprays (400 mcg) for children.

 


Beclomethasone is a corticosteroid that possesses anti-inflammatory activity. Whether inhaled through the nose or into the lungs, the effect of the drug is local (acting directly on the tissue it comes in contact with). The amount absorbed by the body is minimal and therefore the incidence of unwanted effects is low.


Along with its needed effects, beclomethasone dipropionate may cause some unwanted or undesirable effects. Generally, beclomethasone dipropionate is well tolerated and many people will not experience unwanted effects. The severity and duration of these effects are dependant on many factors including duration of therapy, dose, route of administration and individual response. Possible unwanted effects include:

  • sneezing attacks immediately after use (nasal spray only)
  • irritation and burning in the nose (nasal spray only)
  • dry mouth, hoarsness, and loss of voice (oral inhalation only)
  • localized infection of Candida Albicans (thrush) of the mouth and throat


Less common:

  • sore throat
  • cough
  • headache
  • dizziness
  • nausea

Rare:

  • immediate or delayed allergic reaction (e.g. rash, hives, and bronchospasm)
  • flushing, itchiness, and swelling of the eyes, face, lips and throat

 


  • Never use a higher dose than what you have been prescribed. Using higher than recommended doses will cause greater absorption by the body and possibly lead to greater occurrence of unwanted effects. Optimal relief of symptoms may require 1 to 4 weeks of continuous therapy.
  • If symptoms do not improve or the condition worsens, the doctor should be contacted.
  • Treatment with beclomethasone should never be stopped without first consulting your doctor.
  • Discontinuation of beclomethasone requires gradual tapering or you may experience a flare-up of your condition.
  • Inadequate response can often be a result of improper use of the delivery device. Your doctor or pharmacist should instruct you on the correct use of these preparations. Each product comes with a package insert that should be read and then kept as a reference.
  • Children using any of these preparations should do so under the direct supervision of an adult who is familiar with its proper use.
  • People who are using or who have used beclomethasone or any other corticosteroids should inform their doctor as this may change the treatment plan.
  • When people have been treated with oral corticosteroids (e.g. prednisone) for prolonged periods and are being transferred to intranasally or orally inhaled beclomethasone, they may experience withdrawal symptoms (e.g. joint and/or muscular pain, depression). These symptoms should be reported to your doctor, especially if you have associated asthma or another condition in which too rapid a decrease in systemic steroids may cause a severe flare-up of symptoms.
  • Beclomethasone may mask some signs of infection and new infections may appear. The body tends to have a decreased resistance to infection while on this therapy, so anything of this nature should be reported to the doctor.

Drug Interactions: Due to very low absorption at therapeutic doses it is unlikely that there would be any significant drug interactions. However, it is important to tell your doctor and pharmacist of any prescription or over-the-counter medications you are taking.

Use is not recommended in the following situations:

  • allergy to beclomethasone dipropionate or any component of the preparation.
  • people with tuberculosis
  • untreated fungal, bacterial and viral infections
  • children under 5 years of age

Caution is recommended in the following situations:

  • people previously treated for prolonged periods with oral corticosteroids e.g. prednisone

Use in pregnancy: If you suspect that you might be pregnant, consult your doctor.

Use while breastfeeding: It is unlikely that inhaled or intranasal administration would produce high enough levels in breast milk to affect infants.